Alerte sécurité : Des emails frauduleux usurpant l’identité de la SFHTA circulent. Ne communiquez jamais vos coordonnées bancaires (RIB) par email.
Dear WHL Members, Please see the latest issue of the WHL quarterly newsletter, at this link. The WHL Editor and President’s columns summarize exciting recent and upcoming WHL activities, and this issue highlights « Priorities in Hypertension Management » from several of our 2026 Excellence Awards Winners, more World Hypertension Day reports from our Member Societies, and…
Calcium Channel Blockade Versus beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. Hypertension. 2026 Jul;83(7):e26801. Lire 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Jul 28;154(4):e50-e158.…
Essais cliniques Calcium Channel Blockade Versus beta-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial. Hypertension. 2026 Jul;83(7):e26801, Lire Méta-analyses Single Interventions (Pharmacological or Renal Denervation) Are Not Sufficient to Achieve Blood Pressure Control in Resistant Hypertension a Systematic Review and Meta-Analysis. Hypertension. 2026, Lire Adverse Effects and Treatment Discontinuation…
Vous trouverez ci-joint le dernier numéro du bulletin trimestriel de la WHL. Ce numéro de juin contient de nombreux comptes rendus passionnants de la Journée mondiale de l’hypertension, rédigés par vous, nos sociétés membres, et présente les lauréats du Prix d’excellence 2026 ainsi que les œuvres soumises dans le cadre du programme artistique pour enfants.…
Essais cliniques Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial. JACC. 2026 May 12;87(18):2508-2520. Lire Frailty Index Offers Greater Discrimination Than Age for Optimal Blood Pressure Targets: A Pooled Analysis of Two Randomized Trials. Hypertension. 2026 Jun;83(6):e26397. Lire Cohortes Renin-Aldosterone Profiles and Cardiorenal Outcomes in Hypertension: A Nationwide…
Essais cliniques Multifaceted Strategies for Hypertension Control in Low-Income Patients. Mills KT, et al.N Engl J Med. 2026 Apr 9;394(14):1376-1387 Lire Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial. Azizi M, et al; Bax24 investigators. Lancet. 2026 Mar 7;407(10532):988-999 Lire Etudes observationnelles…
Essais cliniques Pharmacogenomics-guided personalized therapy for hypertension: a multicenter randomized trial.Yu M, et al.J Hypertens. 2026 Feb 16 Lire Adherence to Different Dietary Patterns and Subsequent Risk of Total, Ischemic, and Hemorrhagic Stroke.Castro-Barquero S, et al.Stroke. 2026 Feb 23 Lire mHealth Intervention to Improve Hypertension Care in High-Risk Patients. Lakshminarayan K, et al.Hypertension. 2026 Feb 20 Lire Revues Blood-Pressure Targets…
LE TOP de 2025 Facteurs environnementaux et Hypertension artérielle Lire PRISE EN CHARGE des facteurs de risque cardiovasculaire des personnes âgées de 75 ans et plus Lire COMMUNIQUÉ DE LA SFHTA : Clarifications sur la terminologie et le rôle des Infirmiers en Pratique Avancée dans la prise en charge de l’Hypertension Artérielle suite au décret…
Santé mondiale et recommandations WHO global report on hypertension 2025..Farrar J, Frieden T. Lancet. 2025 Nov 15;406(10517):2318-2319. Lire Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023. GBD 2023 Chronic Kidney Disease Collaborators. Lancet. 2025 Nov…
Clinical trials Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.Lamti F, et al.J Hypertens. 2025 Nov 1;43(11):1878-1884. doi: 10.1097/HJH.0000000000004141 LIRE Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. Flack JM, Azizi M, et al; BaxHTN Investigators. N Engl J Med. 2025 Oct 9;393(14):1363- 1374.…